The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on bioMSAR™ Testing

11 Aug 2021 07:00

RNS Number : 2256I
Quadrise Fuels International PLC
11 August 2021
 

11 August 2021

 

Quadrise Fuels International plc

("Quadrise", "QFI", the "Company" and together with its subsidiaries the "Group")

 

Update on bioMSAR™ Testing

 

Quadrise, the supplier of MSAR® and bioMSAR emulsion technology and fuels, which are low-cost, cleaner alternatives to heavy fuel oil and biofuels, is pleased to provide an update on the testing of bioMSAR™ on a medium speed 4-stroke Wärtsilä diesel engine at the VTT facility in Finland and the planned performance and emissions testing with Aquafuel.

 

bioMSAR™ Testing at VTT

 

A comprehensive suite of tests has been completed on a Wärtsilä 4-stroke engine using 5mt of bioMSAR™ fuel produced at QRF. This engine was the same generic type previously used for MSAR® testing, though it has since been modified for dual fuel operation, and this required further work to enable comparison with the earlier MSAR® test results.

 

The final bioMSAR™ test results show the following versus conventional liquid fuels:

 

· Greater than expected calculated CO2 savings - with reductions of 26-28%.

· Engine efficiency increased by up to 7%.

· Highly efficient combustion evidenced by low NOx, CO, particulate and soot emissions.

 

The CO2 savings delivered by existing biofuels are more typically in the region of 10-15%. bioMSARTM 's  formulation can be adjusted to provide the consumers' required CO2 savings at the lowest cost.

 

The results of the test have been shared with MSC and an update on the MSC trial programme will be provided, as appropriate, in due course.

 

Further Testing at Aquafuel

 

Following the successful initial tests reported in February 2021, modifications were carried out by Aquafuel on our Cummins 4-stroke, high-speed diesel engine generating set to allow very accurate performance monitoring, optimisation and measurements to be made.

 

These modifications are now complete and the further bioMSAR™ testing to optimise emissions and engine performance will be carried out at Aquafuel, commencing later this month. Quadrise will be attending the tests at the Aquafuel site and some of this work will be included in the final segment of filming for Quadrise's contribution to the UK Chamber of Shipping's "Making Waves: The Future of Shipping" programme, to be launched on 13 September as part of London International Shipping Week.

 

We expect the results of further testing at Aquafuel to be available by the end of September.

 

 

Mike Kirk, Chairman of Quadrise, said:

 

"We are very pleased to share the positive bioMSAR™ test results - especially those relating to CO2 reductions and higher efficiencies. Quadrise is making great progress on bioMSAR™ testing and development. This work is crucial in enabling Quadrise to offer customers a lower cost renewable fuel solution, alongside our existing MSAR® fuel, and we look forward to sharing further information with shareholders during Q3 2021.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the UK version of the EU Market Abuse Regulation (2014/596) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended and supplemented from time to time.

For further information, please contact:

Quadrise Fuels International Plc

Mike Kirk, Chairman

+44 (0)20 7031 7321

Jason Miles, Chief Executive Officer

ir@quadrisefuels.com

Nominated Adviser

Cenkos Securities plc

Ben Jeynes

Katy Birkin

+44 (0)20 7397 8900

Joint Brokers

Peel Hunt LLP

Richard Crichton

+44 (0)20 7418 8900

David McKeown

Shore Capital Stockbrokers Limited

Toby Gibbs

Fiona Conroy

+44 (0)20 7408 4090

 

Public & Investor Relations

FTI Consulting

Ben Brewerton

+44 (0)20 3727 1000

Ntobeko Chidavaenzi

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDGGDIBUBDGBG
Date   Source Headline
7th Oct 20197:00 amRNSFinal Results for the year ended 30 June 2019
2nd Oct 201911:42 amRNSTotal Voting Rights
30th Sep 20197:18 amRNSResult of Open Offer
27th Sep 20194:09 pmRNSIssue of Warrants
27th Sep 20192:03 pmRNSResult of General Meeting
9th Sep 20197:00 amRNSOpen Offer, Subscription and Notice of GM
6th Sep 20193:00 pmRNSWebsite Update
30th Aug 20195:07 pmRNSIssue of Convertible Security
27th Aug 20197:00 amRNSInvestor Conference Call
23rd Aug 20197:00 amRNSConvertible Securities, Issue of Equity & Warrants
19th Aug 20197:00 amRNSFunding Update
14th Aug 20197:00 amRNSMOU with Merlin Energy Resources Ltd
12th Aug 20194:40 pmRNSSecond Price Monitoring Extn
12th Aug 20194:36 pmRNSPrice Monitoring Extension
12th Aug 201912:02 pmRNSPrice Monitoring Extension
12th Aug 20197:00 amRNSMemorandum of Agreement with European Oil Refiner
23rd Jul 201911:08 amRNSStmnt re Share Price Movement
10th Jul 20197:00 amRNSDirector/PDMR Shareholding
3rd Jul 20197:00 amRNSPDMR Shareholding and Transfer of Share Options
27th Jun 20195:20 pmRNSIssue of Share Options
24th Jun 20194:40 pmRNSSecond Price Monitoring Extn
24th Jun 20194:35 pmRNSPrice Monitoring Extension
24th Jun 201911:41 amRNSAppointment of Joint Broker
13th Jun 20197:00 amRNSKSA Services Agreement and Grant of Warrants
11th Jun 20197:00 amRNSAgency Agreement for Mexico
30th May 20198:59 amRNSReplacement: MOA with Al Khafrah Holding Group
30th May 20197:00 amRNSMOU with Al Khafrah Holding Group
20th May 20193:00 pmRNSUpdate on Test Programme and Termination of MOA
15th May 20197:00 amRNSInvestor Conference Call
13th May 20197:00 amRNSMOU with API POLY-GCL Alliance
8th May 20193:23 pmRNSHolding(s) in Company
8th May 20197:00 amRNSKuwait Agency Agreement and MoU
23rd Apr 201911:40 amRNSDirectorate Change
27th Mar 20197:00 amRNSMemorandum of Understanding with Bitumina
25th Mar 20197:00 amRNSHalf-year Report
18th Mar 20194:40 pmRNSSecond Price Monitoring Extn
18th Mar 20194:35 pmRNSPrice Monitoring Extension
6th Mar 20197:00 amRNSRepresentation Agreement and Grant of Warrants
26th Feb 20197:00 amRNSKuwait Services Agreement & Grant of Warrants
13th Feb 20197:00 amRNSInvestor Site Visit
31st Jan 201912:00 pmRNSTotal Voting Rights
21st Jan 20197:00 amRNSResult of Open Offer
7th Jan 20195:11 pmRNSExtension of Open Offer Closing Date
12th Dec 20187:01 amRNSInvestor Conference Call
12th Dec 20187:00 amRNSChange of Adviser
7th Dec 20187:00 amRNSOpen Offer
30th Nov 20184:07 pmRNSResult of AGM
30th Nov 20187:00 amRNSCo-Marketing & Project Development Agreement
28th Nov 20187:00 amRNSMOU and MSAR® Test Programme
26th Nov 20187:00 amRNSExtension of Contracts with AkzoNobel

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.